Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
Authors
Keywords
Cancer treatment, Apoptosis, STAT signaling, Renal cell carcinoma, Tumor angiogenesis, Signal inhibition, MAPK signaling cascades, Small interfering RNAs
Journal
PLoS One
Volume 8, Issue 12, Pages e81657
Publisher
Public Library of Science (PLoS)
Online
2013-12-07
DOI
10.1371/journal.pone.0081657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Agents and Approaches for Advanced Renal Cell Carcinoma
- (2012) Robert Figlin et al. JOURNAL OF UROLOGY
- Interferon-α Induces G1 Cell-Cycle Arrest in Renal Cell Carcinoma Cells Via Activation of Jak-Stat Signaling
- (2011) Donghao Shang et al. CANCER INVESTIGATION
- An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells
- (2011) YuMing Guo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
- (2011) Jing-Shan Tong et al. PLoS One
- Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
- (2011) Jian feng Zhu et al. PLoS One
- STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma
- (2010) A Horiguchi et al. BRITISH JOURNAL OF CANCER
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloproliferative disorders
- (2008) R. L. Levine et al. BLOOD
- Enhanced co-expression of β-tubulin III and choline acetyltransferase in neurons from mouse embryonic stem cells promoted by icaritin in an estrogen receptor-independent manner
- (2008) Zhiqiang Wang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
- (2008) Sandra Rebouissou et al. NATURE
- Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells
- (2007) Yan-bo Wo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now